Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections

NCT00542399 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rabin Medical Center